Norges Bank Invests $2.18 Billion in Danaher Corporation $DHR

Norges Bank bought a new stake in shares of Danaher Corporation (NYSE:DHR) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 9,510,336 shares of the conglomerate’s stock, valued at approximately $2,177,106,000. Norges Bank owned about 1.35% of Danaher as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of DHR. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter worth $25,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher in the 4th quarter worth $26,000. WFA of San Diego LLC purchased a new position in shares of Danaher in the 2nd quarter worth $26,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher in the 3rd quarter worth $27,000. Finally, Financial Life Planners purchased a new position in shares of Danaher in the 3rd quarter worth $32,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on DHR shares. Evercore lifted their price objective on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Morgan Stanley cut their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 target price on Danaher in a research note on Friday, April 17th. TD Cowen reduced their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Finally, Argus reduced their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $238.24.

Danaher Stock Up 1.2%

Shares of Danaher stock opened at $182.73 on Friday. The firm’s 50 day moving average price is $182.11 and its 200-day moving average price is $207.48. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a market cap of $129.33 billion, a P/E ratio of 35.34, a PEG ratio of 2.41 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the firm earned $1.88 EPS. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, sell-side analysts predict that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.